Tasisulam sodium (LY573636 sodium) as third-line treatment in patients with unresectable, metastatic non-small-cell lung cancer: a phase-II study (Q33401226)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tasisulam sodium (LY573636 sodium) as third-line treatment in patients with unresectable, metastatic non-small-cell lung cancer: a phase-II study |
scientific article |
Statements
1 reference
Tasisulam sodium (LY573636 sodium) as third-line treatment in patients with unresectable, metastatic non-small-cell lung cancer: a phase-II study (English)
1 reference
Giorgio V Scagliotti
1 reference
Silvia Novello
1 reference
Robert Ilaria
1 reference
J von Pawel
1 reference
Juergen R Fischer
1 reference
Sabine Ermisch
1 reference
Dinesh P de Alwis
1 reference
Joan Andrews
1 reference
Martin Reck
1 reference
Lucio Crino
1 reference
Corinna Eschbach
1 reference
Christian Manegold
1 reference
1 June 2012
1 reference
1 reference
1053-1057
1 reference
Identifiers
1 reference
1 reference